An observational study of the efficacy of azithromycin in erythema annulare centrifugum
Authors:
- 3 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 43 (3) , 296-299
Abstract
Erythema annulare centrifugum (EAC) is a form of figurate erythema consequent to a cutaneous hypersensitivity reaction to an underlying agent. In the present study, we aimed to assess the role of oral azithromycin in cases of idiopathic EAC. We performed an open trial of azithromycin in 10 patients with idiopathic EAC. Histopathological examination of biopsies was performed to exclude any alternative diagnosis and to assess the depth of the infiltrate. Patients were administered oral azithromycin 250 mg once daily until clinical resolution of the disease, and followed up regularly to monitor for possible relapse. Histopathological examination of the 10 biopsies revealed superficial pattern in 3, deep pattern in 2 and mixed pattern in the remaining 5. Of the 10 patients, 8 responded to azithromycin 250 mg, with no relapse during follow-up. Oral azithromycin might be a promising therapy in cases of idiopathic EAC. Cases with a superficial pattern respond earlier than cases with a deep pattern.Keywords
This publication has 8 references indexed in Scilit:
- Pediatric Erythema Annulare Centrifugum Treated with Oral Fluconazole: A Retrospective SeriesPediatric Dermatology, 2016
- Erythema Annulare Centrifugum: Analysis of Associated Diseases and Clinical Outcomes according to Histopathologic ClassificationAnnals of Dermatology, 2016
- Erythromycin as a safe and effective treatment option for erythema annulare centrifugumIndian Journal of Dermatology, 2015
- Anti-inflammatory Activity of Azithromycin as Measured by Its NF-кB Inhibitory ActivityOcular Immunology and Inflammation, 2010
- Azithromycin Suppresses Activation of Nuclear Factor-kappa B and Synthesis of Pro-inflammatory Cytokines in Tracheal Aspirate Cells From Premature InfantsPediatric Research, 2007
- Erythema Annulare CentrifugumThe American Journal of Dermatopathology, 2003
- Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial☆, ☆☆Journal of the American Academy of Dermatology, 2000
- ERYTHEMA ANNULARE CENTRIFUGUM TREATED WITH SULFONAMIDE COMPOUNDSArchives of Dermatology, 1949